Autopsy report · NCT03795233
Fecal Microbiota Transplant for Primary CDI
Cause of deathDrug or device supply, also staffing, sites or logistics
“The study was terminated after a covid-related suspension and the unavailability of drug.”
Life of this trial
- Registered 9 months before it started.
- Ran for about 1 year 5 months before it stopped.
- 5 participants enrolled.
- Results were posted on the registry 11 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Boston Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Clostridium Difficile Infection
- Interventions
- Fecal microbiota transplant G3 capsules; Oral Vancomycin alone
- Participants
- 5
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Inflammation-Induced CNS Glutamate Changes in Depression
“The study was suspended in March 2020 due to the COVID-19 pandemic and ultimately was terminated as it is not safe to test a potent anti-inflammatory drug with ongoing surges of COVID-19.” - New Formulations of Propafenone to Treat Atrial Fibrillation
“Study halted/terminated prematurely due to COVID.” - Effects of E-Cigarette Power and Nicotine Content in Dual Users and Vapers
“Study terminated due to COVID” - Acceptability, Feasibility and Safety of a Yoga Program for Chronic Pain in Sickle Cell Disease
“Study terminated due to COVID-19 pandemic.” - Effect of Classic Ballet Practice on School Children's Postural Balance
“The study has been suspended because COVID pandemic.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.